- Home
- ESEA vs ESPR Comparison
ESEA vs ESPR Comparison
Compare ESEA & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- ESPR
- Stock Information
- Founded
- ESEA 2005
- ESPR 2008
- Country
- ESEA Greece
- ESPR United States
- Employees
- ESEA N/A
- ESPR N/A
- Industry
- ESEA Marine Transportation
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- ESEA Consumer Discretionary
- ESPR Health Care
- Exchange
- ESEA Nasdaq
- ESPR Nasdaq
- Market Cap
- ESEA 432.8M
- ESPR 445.6M
- IPO Year
- ESEA 2006
- ESPR 2013
- Fundamental
- Price
- ESEA $61.82
- ESPR $2.77
- Analyst Decision
- ESEA Strong Buy
- ESPR Buy
- Analyst Count
- ESEA 1
- ESPR 6
- Target Price
- ESEA $62.00
- ESPR $6.50
- AVG Volume (30 Days)
- ESEA 45.1K
- ESPR 6.0M
- Earning Date
- ESEA 08-13-2025
- ESPR 11-06-2025
- Dividend Yield
- ESEA 4.51%
- ESPR N/A
- EPS Growth
- ESEA 0.63
- ESPR N/A
- EPS
- ESEA 17.09
- ESPR N/A
- Revenue
- ESEA $221,034,167.00
- ESPR $268,125,000.00
- Revenue This Year
- ESEA $9.61
- ESPR $10.59
- Revenue Next Year
- ESEA $1.86
- ESPR N/A
- P/E Ratio
- ESEA $3.72
- ESPR N/A
- Revenue Growth
- ESEA 7.73
- ESPR N/A
- 52 Week Low
- ESEA $24.58
- ESPR $0.69
- 52 Week High
- ESEA $65.50
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- ESEA 55.76
- ESPR 74.18
- Support Level
- ESEA $61.08
- ESPR $2.37
- Resistance Level
- ESEA $64.99
- ESPR $2.90
- Average True Range (ATR)
- ESEA 2.07
- ESPR 0.17
- MACD
- ESEA -0.43
- ESPR 0.01
- Stochastic Oscillator
- ESEA 43.29
- ESPR 83.95
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.